May 17, 2021

The Medicine Maker’s Power List 2021 Honors Akron Biotech CEO Dr. Claudia Zylberberg

April 19, 2021

Akron Biotech appoints new Scientific Advisory Board, further expanding its cell and gene therapy industry expertise

February 25, 2021

De-risking the Manufacturing of Cell Therapies through Virus-Inactivated Products, Upcoming Webinar Hosted by Xtalks

January 20, 2021

Akron Biotech Signs Exclusive Global Agreement with Octapharma to Produce Virally Inactivated Human AB Serum Derived from Octaplas® for the Cell Therapy Market

October 26, 2020

Akron Biotech Acquires Cytiva FlexFactory for the Manufacture of Plasmid DNA